Atrial fibrillation after coronary bypass: etiology and pharmacologic prevention

V K S Jayam1, G C Flaker, J W Jones

  • 1Division of Cardiology, University of Missouri-Columbia, Columbia, MO 65201, USA.

Cardiovascular Surgery (London, England)
|October 3, 2002
PubMed

Insights

Atrial Fibrillation (AF) is a common complication after coronary bypass surgery. This review examines pharmacologic strategies to prevent post-bypass AF, a persistent challenge for cardiac care teams.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Pharmacology

Background:

  • Coronary bypass surgery is a common procedure in the US, with over 400,000 patients annually.
  • Atrial Fibrillation (AF) is the most frequent complication post-coronary bypass surgery.
  • Post-bypass AF presents significant physiological challenges and impacts healthcare resource utilization.

Purpose of the Study:

  • To review the existing literature on post-coronary bypass surgery Atrial Fibrillation.
  • To emphasize pharmacologic interventions for the prevention of post-bypass AF.
  • To explore the unique features of AF occurrence related to perioperative circumstances.

Main Methods:

  • Systematic review of published literature on post-coronary bypass surgery AF.
  • Analysis of clinical observations regarding perioperative factors influencing AF.
  • Evaluation of pharmacologic and non-pharmacologic therapies for AF prevention.

Main Results:

  • Atrial Fibrillation remains a significant and persistent complication after coronary bypass surgery.
  • Numerous therapies have been investigated for AF prevention, with varying degrees of success.
  • The occurrence of post-bypass AF exhibits unique characteristics tied to the perioperative period.

Conclusions:

  • Pharmacologic prevention strategies for post-bypass AF require further investigation and optimization.
  • Understanding perioperative influences is crucial for mitigating AF risk.
  • Continued research is needed to address this tenacious clinical problem.

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...